9 July 2026

Drugs TGA

Emerging side effects of unapproved peptides

9 July 2026

ANCA-associated vasculitis FDA Pharmaceuticals

Avacopan trial retracted as regulators diverge

9 July 2026

ANCA-associated vasculitis Pharmaceuticals

CSL issues open letter as EU moves to revoke avacopan approval

28 May 2026

Diabetes Pharmaceuticals

TGA green light for first drug to slow type 1 diabetes

14 May 2026

Drugs Pharmaceuticals TGA

Peptide craze sparks Lancet warning

16 April 2026

Public Health TGA

Travel, gaps in jabs drive Australia’s measles comeback

16 April 2026

Drugs TGA

Is healthcare behind the curve on peptides?

2 April 2026

FDA Pharmaceuticals

FDA liver alert for avacopan

19 March 2026

Pharmaceuticals TGA

More treatment flexibility for myasthenia gravis patients

5 March 2026

Pharmaceuticals TGA

TGA’s February safety updates

5 March 2026

Pharmaceuticals TGA

More fake GLP-1 weight loss drugs trigger TGA alert

27 November 2025

TGA

TGA makes final decision on vitamin B6 regulation

13 November 2025

Cardiology Supplements TGA

Long-term melatonin linked to higher heart failure risk

30 October 2025

Diabetes Pharmaceuticals TGA

Oral GLP-1 set for TGA submission

7 August 2025

Cannabis Telehealth TGA

TGA to launch medicinal cannabis regulation consultation

7 August 2025

AI Digital Health TGA Uncategorized

Vendors want AI scribe clarity, welcome TGA review